Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)


Editorial
Challenges at the Pharmaceutical–Physician Boundary
Quentin Rae-Grant
(PDF)

Guest Editorial
Suicide: The Persisting Challenge
Isaac Sakinofsky
(PDF)


In Review
The Neurobiology of Suicide and Suicidality

Kees van Heeringen

(PDF)

Assessing Suicidal Youth With Antisocial, Borderline, or Narcissistic Personality Disorder
Paul S Links, Brent Gould, Ruwan Ratnayake

(PDF)


Original Research
Sexsomnia — A New Parasomnia?

Colin M Shapiro, Nikola N Trajanovic, J Paul Fedoroff

(PDF)

A Case–Control Study on Psychological Symptoms in Sleep Apnea-Hypopnea Syndrome
Weihua Yue, Wei Hao, Pozi Liu, Tieqiao Liu, Ming Ni, Qi Guo

(PDF)

Suicide Attempts in Turkey: Results of the WHO–EURO Multicentre Study on Suicidal Behaviour
Halise Devrimci-Ozguven, Is1k Say1l

(PDF)


Review Paper
Adverse Effects Associated With Physical Restraint

Wanda K Mohr, Theodore A Petti, Brian D Mohr

(PDF)


Brief Communication
Insight and Neuropsychological Function in Patients With Schizophrenia and Bipolar Disorder With Psychotic Features

Luca Arduini, Artemis Kalyvoka, Paolo Stratta, Osvaldo Rinaldi, Enrico Daneluzzo, Alessandro Rossi

(PDF)

Time of Day Influences Nonattendance at Urgent Short-Term Mental Health Unit in Victoria, British Columbia
Rivian Weinerman, Vi Glossop, Randy Wong, Lara Robinson, Karen White, Rif Kamil

(PDF)

Diabetes Mellitus and Impaired Glucose Tolerance in Patients With Schizophrenia
Mythily Subramaniam, Siow-Ann Chong, Elaine Pek

(PDF)


Book Reviews
(PDF)

Language Impairment and Psychopathology in Infants, Children and Adolescents.
Reviewed by
JH Beitchman, MD

Women’s Mental Health: A Comprehensive Textbook.
Reviewed by
Gail Erlick Robinson, MD, DPsych, FRCPC

Psychiatric and Cognitive Disorders in Parkinson’s Disease.
Reviewed by
Erwin K Koranyi, MD

Un jour la santé.
Reviewed by
Paul Beaudry, MD, FRCP

Seeking Safety: A Treatment Manual for Posttraumatic Stress Disorder and Substance Abuse.
Reviewed by
George A Fraser, MD

Treatment-Resistant Mood Disorders.
Reviewed by
Sagar V Parikh, MD, FRCPC


Letters to the Editor
(PDF)

QTc Prolongation: Chlorpromazine and High-Dosage Olanzapine

Should Lipids be Monitored During the First Year of Treatment with an Atypical Antipsychotic?

Quetiapine May Induce Mania: A Case Report

Insight, Knowledge, and Beliefs About Illness in First-Episode Psychosis

The Symptoms of Atypical Depression

Potential Risk of Diabetes Mellitus With the Use of Atypical Antipsychotic Medication

Clozapine-Induced Aplastic Anemia in a Patient With Parkinson’s Disease

Early-Onset Obsessive–Compulsive Disorder

Treatment Noncompliance With Orally Disintegrating Olanzapine Tablets

junecover.jpg - 43796 Bytes

Vol 48, No 5 June 2003 juin

ISSN 1497-0015

In the July Issue

Adverse Effects Associated
With Physical Restraint

Wanda K Mohr, Theodore A Petti, Brian D Mohr

Sexsomnia - A New Parasomnia?
Colin M Shapiro, Nikola N Trajanovic, J Paul Fedoroff


CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2002 | Index RCP des auteurs 2002
Subject Index to 2002 | Index RCP des sujets 2002
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil



On line viewing supported by an Unrestricted Educational Grant from: Lilly